Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
Angewandte Chemie (International Ed. in English)
|
December 28, 2021
Protonation-Induced Chirality Drives Separation by Differential Ion Mobility Spectrometry
Christian Ieritano, J C Yves Le Blanc, Bradley B Schneider, et al.
Journal of Drugs in Dermatology : JDD
|
December 31, 2008
Etanercept in the treatment of palmoplantar pustulosis
R Bissonnette, Y Poulin, C Bolduc, et al.
The British Journal of Dermatology
|
December 21, 2011
Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial
R Bissonnette, Y Poulin, Y Zhou, et al.
Analytical Chemistry
|
April 10, 2025
Towards Generalizable <i>In Silico</i> Predictions of Differential Ion Mobility Using Machine Learning and Customized Fingerprint Engineering
Cailum M K Stienstra, Christopher R M Ryan, Daniel Demczuk, et al.
Immunological Reviews
|
December 1, 1994
Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals
D R Green, A Mahboubi, W Nishioka, et al.
Immunity
|
April 1, 1995
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway
E Gulbins, R Bissonnette, A Mahboubi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 22, 2024
Harmonizing body surface area assessments between the Eczema Area and Severity Index, SCORing Atopic Dermatitis, and handprint methods utilizing one shared measurement-A proposal to improve efficiency and reduce error in atopic dermatitis trials
M E Jacobson, R S Seshadri, R Bissonnette, et al.
The British Journal of Dermatology
|
June 6, 2017
Secukinumab sustains good efficacy and favourable safety in moderate-to-severe psoriasis after up to 3 years of treatment: results from a double-blind extension study
R Bissonnette, T Luger, D Thaçi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 13, 2019
Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statement
Y A Leshem, R Bissonnette, C Paul, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1991
Immunoregulatory activity of the T-cell receptor alpha chain demonstrated by retroviral gene transfer
D R Green, R Bissonnette, H G Zheng, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
Angewandte Chemie (International Ed. in English)
|
December 28, 2021
Protonation-Induced Chirality Drives Separation by Differential Ion Mobility Spectrometry
Christian Ieritano, J C Yves Le Blanc, Bradley B Schneider, et al.
Journal of Drugs in Dermatology : JDD
|
December 31, 2008
Etanercept in the treatment of palmoplantar pustulosis
R Bissonnette, Y Poulin, C Bolduc, et al.
The British Journal of Dermatology
|
December 21, 2011
Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial
R Bissonnette, Y Poulin, Y Zhou, et al.
Analytical Chemistry
|
April 10, 2025
Towards Generalizable <i>In Silico</i> Predictions of Differential Ion Mobility Using Machine Learning and Customized Fingerprint Engineering
Cailum M K Stienstra, Christopher R M Ryan, Daniel Demczuk, et al.
Immunological Reviews
|
December 1, 1994
Promotion and inhibition of activation-induced apoptosis in T-cell hybridomas by oncogenes and related signals
D R Green, A Mahboubi, W Nishioka, et al.
Immunity
|
April 1, 1995
FAS-induced apoptosis is mediated via a ceramide-initiated RAS signaling pathway
E Gulbins, R Bissonnette, A Mahboubi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
February 22, 2024
Harmonizing body surface area assessments between the Eczema Area and Severity Index, SCORing Atopic Dermatitis, and handprint methods utilizing one shared measurement-A proposal to improve efficiency and reduce error in atopic dermatitis trials
M E Jacobson, R S Seshadri, R Bissonnette, et al.
The British Journal of Dermatology
|
June 6, 2017
Secukinumab sustains good efficacy and favourable safety in moderate-to-severe psoriasis after up to 3 years of treatment: results from a double-blind extension study
R Bissonnette, T Luger, D Thaçi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
March 13, 2019
Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey-based position statement
Y A Leshem, R Bissonnette, C Paul, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1991
Immunoregulatory activity of the T-cell receptor alpha chain demonstrated by retroviral gene transfer
D R Green, R Bissonnette, H G Zheng, et al.
Page
of 11